Proteotype is a pioneering diagnostics company dedicated to the development of advanced multi-cancer early detection and personalised medicine tests that measure the host response to tumour development. By leveraging cutting-edge technologies and comprehensive research, Proteotype aims to revolutionise cancer diagnostics and improve early detection, ultimately enhancing patient outcomes and survival rates.
| Website | https://proteotype.com |
| Employees | 6 (3 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Cancer Diagnostics, Blood Test Analysis, Early Cancer Detection, Proteomic Analysis, Cancer Biomarkers, Molecular Diagnostics, Precision Oncology, Biomarker Discovery, Liquid Biopsy, Diagnostic Testing, Medical Diagnostics, Disease Diagnostics, Proteomics Research, Health Diagnostics, Healthcare Technology, Clinical Diagnostics, Personalized Medicine, Advanced Diagnostics, In Vitro Diagnostics, Biotechnology |
| Competitors | Thermo Fisher Scientific, Illumina, QIAGEN, Genentech, Myriad Genetics, Lexent Bio, Exact Sciences, Foundation Medicine, Guardant Health, Bristol Myers Squibb +42 more (view full list) |
Looking for a particular Proteotype Diagnostics employee's phone or email?
Proteotype Diagnostics Questions
Emma Yates is the Co-Founder of Proteotype Diagnostics.
3 people are employed at Proteotype Diagnostics.
Proteotype Diagnostics is based in Cambridge, England.
Top Proteotype Diagnostics Employees
-
12
-
Steve W.
Senior Scientist at Proteotype Diagnostics
Cambridge, GB2
